Revenue Breakdown
Composition ()
No data
Revenue Streams
Profitability & Margins
Evaluating the bottom line, AnaptysBio Inc maintains a gross margin of 100.00%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 45.47%, while the net margin is 19.80%. These profitability ratios, combined with a Return on Equity (ROE) of -308.02%, provide a clear picture of how effectively ANAB converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, ANAB competes directly with industry leaders such as TRVI and TNGX. With a market capitalization of $1.52B, it holds a significant position in the sector. When comparing efficiency, ANAB's gross margin of 100.00% stands against TRVI's N/A and TNGX's 100.00%. Such benchmarking helps identify whether AnaptysBio Inc is trading at a premium or discount relative to its financial performance.
